Dexcom Inc. Aktie
73,70 €
Deine Einschätzung
Dexcom Inc. Aktie
Was spricht für und gegen Dexcom Inc. in den nächsten Jahren?
Pro
Kontra
Rendite von Dexcom Inc. im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Dexcom Inc. | 0,79 % | 3,32 % | 3,04 % | -30,10 % | -3,15 % | -4,28 % | -18,78 % |
Henry Schein Inc. | 0,10 % | -3,35 % | -0,33 % | 1,44 % | -9,20 % | -19,30 % | 15,46 % |
Teleflex Inc. | -1,02 % | -1,52 % | -5,34 % | -51,73 % | -41,96 % | -58,69 % | -68,34 % |
Baxter International | -0,16 % | -3,59 % | -7,81 % | -24,54 % | -12,18 % | -61,40 % | -67,09 % |
Kommentare
News

2 Stocks to Buy on the Dip and Hold for 10 Years
One of Warren Buffett's famous pieces of investing advice is to be greedy when others are fearful. One way to apply this wisdom is to look for companies that have lagged the market recently but

Dexcom Schedules Second Quarter 2025 Earnings Release and Conference Call for July 30, 2025 at 4:30 p.m. Eastern Time.
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2025 financial results after market close on Wednesday, July 30, 2025. Management will hold a conference call

Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025
DexCom, Inc., the global leader in glucose biosensing, today released its "Dexcom State of Type 2 Report: Access and Attitudes Across the United States" ahead of the 85th Scientific Sessions of the